Become A MyoVista® Distributor

The MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device is a significant innovation in electrocardiography. MyoVista wavECG technology has been developed in response to the recent understanding that most forms of heart disease are associated with left ventricular (LV) relaxation abnormalities and left ventricular diastolic dysfunction (LVDD). With the MyoVista wavECG, physicians are provided additional heart disease risk information beyond conventional ECG information. This additional information assists physicians in making informed decisions regarding risk stratification and whether a patient should receive further testing, evaluation and or treatment. The MyoVista wavECG Device has the potential to reduce healthcare costs while saving lives through improved clinical outcomes and patient/provider satisfaction.